Want to join the conversation?
$MRK said its 1Q16 Pharmaceutical sales fell 2% to $8.1Bil, including a 4% negative FX impact. Animal Health sales was $829MM, flat YoverY. $MRK said "The Global Human Health business performed well in 1Q. The JANUVIA franchise demonstrated strong growth, and we remain pleased with the ongoing launch of KEYTRUDA around the world."
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.